ArticleMolecular microbiology2016

CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.

Caroline L Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.